Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis
2019 · BMC Pulmonary Medicine · 48 citations
https://doi.org/10.1186/s12890-019-0868-9
B
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
31
Papers
268
Citations
9
h-index
9
i10-index
Bo Mi Gil is an academic researcher from The Catholic University of Korea Bucheon St. Mary's Hospital. The author has contributed to research in topics: Lung Cancer Diagnosis and Treatment & Radiomics and Machine Learning in Medical Imaging & Cancer Immunotherapy and Biomarkers. The author has an h-index of 9, co-authored 27 publications.
ORCID: 0000-0003-0576-5830Papers by this author
worksDeepBTS: Prediction of Recurrence-free Survival of Non-small Cell Lung Cancer Using a Time-binned Deep Neural Network
2020 · Scientific Reports · 43 citations
https://doi.org/10.1038/s41598-020-58722-z
The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy
2021 · BMC Cancer · 28 citations
https://doi.org/10.1186/s12885-020-07727-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat